Mine Kanat PEKTAŞ, Mehmet Gazi BOYACI, Hilal KOYUNCU, Ahmet Afşin KUNDAK, Ayhan PEKTAŞ

Timeliness of postnatal surgery in newborns with open neural tube defects: a single center experience

Background. This study aims to evaluate the experience of a tertiary health center on the timeliness of postnatal management in newborns with open neural tube defects (NTDs). Methods. This is a retrospective review of 38 neonates with NTDs who were treated surgically at a tertiary health care center between January 2009 and January 2019. Five neonates with genetic syndromes were excluded. Results. Twenty-six neonates with NTD underwent surgery on the first postnatal day while 12 neonates with NTD had surgery after the first postnatal day. The reasons for the latency in operative treatment were the delay in the referral of the affected newborn from other health care centers (n=8) and the transient abnormalities in coagulation tests (n=4). Rural residence was significantly more frequent, gestational age at delivery was significantly lower, preterm delivery was significantly more frequent and prenatal diagnosis was significantly less frequent in neonates that underwent surgery for NTD repair after the first postnatal day (p=0.001, p=0.048, p=0.024 and p=0.003 respectively). Postoperative motor dysfunction was significantly more severe (p=0.002), postoperative complications were significantly more frequent (p=0.008), the reoperation and postoperative mortality rates were significantly higher (p=0.009 and p=0.048 respectively) and the duration of hospital stay was significantly longer (p=0.033) for the neonates who underwent surgery after the first postnatal day. Conclusions. Our study appears to favor the early repair of NTD’s within the first 24 hours of life. Such an approach may reduce the risk of infectious and neurological complications significantly.

PDF

___

1. Greene ND, Copp AJ. Neural tube defects. Annu Rev Neurosci 2014; 37: 221-242.

2. Aygün C, Kurucu S, Çakmak-Çelik F, Dağçınar A, Tanyeri B, Küçüködük Ş. Experience of a tertiary care center on 100 newborns with neural tube defects. Turk J Pediatr 2013; 55: 359-364.

3. Padmanabhan R. Etiology, pathogenesis and prevention of neural tube defects. Congenit Anom (Kyoto) 2006; 46: 55-67.

4. Kondo A, Matsuo T, Morota N, Kondo AS, Okai I, Fukuda H. Neural tube defects: risk factors and preventive measures. Congenit Anom (Kyoto) 2017; 57: 150-156.

5. Nazki FH, Sameer AS, Ganaie BA. Folate: metabolism, genes, polymorphisms and the associated diseases. Gene 2014; 533: 11-20.

6. Toru HS, Sanhal CY, Uzun ÖC, Ocak GA, Mendilcioğlu İ, Karaveli FŞ. Associated anomalies with neural tube defects in fetal autopsies. J Matern Fetal Neonatal Med 2016; 29: 798-802.

7. Oakeshott P, Hunt GM, Poulton A, Reid F. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol 2010; 52: 749-753.

8. Wang Y, Hu J, Druschel CM, Kirby RS. Twenty-fiveyear survival of children with birth defects in New York State: a population-based study. Birth Defects Res A Clin Mol Teratol 2011; 91: 995-1003.

9. Shin M, Kucik JE, Siffel C, et al. Improved survival among children with spina bifida in the United States. J Pediatr 2012; 161: 1132-1137.

10. Kancherla V, Druschel CM, Oakley GP Jr. Populationbased study to determine mortality in spina bifida: New York State Congenital Malformations Registry, 1983 to 2006. Birth Defects Res A Clin Mol Teratol 2014; 100: 563-575.

11. Zaganjor I, Sekkarie A, Tsang BL, et al. Describing the prevalence of neural tube defects worldwide: a systematic literature review. PLoS ONE 2016; 11: e0151586.

12. Copp AJ, Greene ND. Genetics and development of neural tube defects. J Pathol 2010; 220: 217-230.

13. Pinto FC, Matushita H, Furlan AL, et al. Surgical treatment of myelomeningocele carried out at ‘time zero’ immediately after birth. Pediatr Neurosurg 2009; 45: 114-118.

14. Bakker MK, Kancherla V, Canfield MA, et al. Analysis of mortality among neonates and children with spina bifida: an International Registry-Based Study, 2001-2012. Paediatr Perinat Epidemiol 2019; 33: 436-448.

15. Kancherla V, Ma C, Grant G, Lee HC, Hintz SR, Carmichael SL. Factors associated with early neonatal and first-year mortality in infants with myelomeningocele in California from 2006 to 2011. Am J Perinatol 2020. doi: 10.1055/s-0040-1712165.

16. Glinianaia SV, Morris JK, Best KE, et al. Long-term survival of children born with congenital anomalies: a systematic review and meta-analysis of populationbased studies. PLoS Med 2020; 17: e1003356.

17. Tarcan T, Önol FF, İlker Y, Alpay H, Şimşek F, Özek M. The timing of primary neurosurgical repair significantly affects neurogenic bladder prognosis in children with myelomeningocele. J Urol 2006; 176: 1161-1165.

18. Oncel MY, Ozdemir R, Kahilogulları G, Yurttutan S, Erdeve O, Dilmen U. The effect of surgery time on prognosis in newborns with meningomyelocele. J Korean Neurosurg Soc 2012; 51: 359-362.

19. Rodrigues ABD, Krebs VLJ, Matushita H, de Carvalho WB. Short-term prognostic factors in myelomeningocele patients. Childs Nerv Syst 2016; 32: 675-680.

20. Attenello FJ, Tuchman A, Christian EA, et al. Infection rate correlated with time to repair of open neural tube defects (myelomeningoceles): an institutional and national study. Childs Nerv Syst 2016; 32: 1675-1681.

21. Radcliff E, Cassell CH, Laditka SB, et al. Factors associated with the timeliness of postnatal surgical repair of spina bifida. Childs Nerv Syst 2016; 32: 1479-1487.